Visa to launch contactless payment wristbands at Eurovision contest in collaboration with Gemalto
May 10, 2016 05:01 am UTC| Business
AMSTERDAM, May 10, 2016 -- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is collaborating with Visa, one of the world's largest payment providers, to equip visitors at the 2016 Eurovision Song...
Afognak Native Corporation Recovers $3.665M of Cyber Fraud Funds
May 09, 2016 22:30 pm UTC| Business
ANCHORAGE, AK, May 9, 2016 -- Afognak Native Corporation announced today that it has recovered nearly all of the stolen funds that were fraudulently obtained by an international criminal ring during a sophisticated cyber...
CHC Group Receives Court Approval of "First Day" Motions to Support Business Operations
May 09, 2016 20:58 pm UTC| Business
IRVING, TEXAS, May 9, 2016 -- CHC Group (OTC Pink Sheets:HELIQ) (the "Company" or "CHC") today announced the Company has received approval from the United States Bankruptcy Court for the Northern District of Texas for its...
CHC Group Appoints William L. Transier to Board of Directors
May 09, 2016 20:54 pm UTC| Business
IRVING, TEXAS, May 9, 2016 -- CHC Group (OTC Pink Sheets:HELIQ) (the "Company" or "CHC") today announced the appointment of William L. Transier to its Board of Directors, effective immediately. An independent, Class II...
May 09, 2016 20:25 pm UTC| Business
AMSTERDAM, The Netherlands, May 9, 2016 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced the nomination of Jack Kaye to stand for election to uniQure's Board of Directors. Mr. Kaye, who will...
May 09, 2016 20:16 pm UTC| Business
AMSTERDAM, the Netherlands, May 9, 2016 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced the nomination of Jack Kaye to stand for election to uniQure's Board of Directors. Mr. Kaye, who will...
Galapagos starts Phase 1 study with potentiator GLPG2451 for CF
May 09, 2016 20:10 pm UTC| Business
MECHELEN, Belgium, May 9, 2016 -- Galapagos NV (Euronext NASDAQ: GLPG) announces the start of a Phase 1 study with potentiator GLPG2451 for cystic fibrosis (CF). Following GLPG1837, GLPG2451 is the second potentiator...
US–India Trade Talks Race Toward USD 500 Billion Goal